In this issue:
Non-invasive diagnostic tests for CAD
CV outcomes associated with canagliflozin
CV risk with inhaled long-acting bronchodilators
Aspirin use in patients with previous PCI
Use of high-risk plaque detection for stratifying patients
hsTnT identifies very-low-risk patients with possible ACS
Incomplete revascularisation after PCI
A post-discharge bleeding risk score after PCI
No evidence of neurocognitive adverse events with alirocumab
Clinical features and outcomes of type 2 MI
Please login below to download this issue (PDF)